Nutex Health, Inc. (NUTX) Income Statement
NUTX 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsNUTX revenue and net income
Where NUTX's revenue goes
2025Each bar shows an amount and its share of revenue. NUTX kept 8.1% of revenue as net income.
NUTX profit margins
NUTX growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +82.4% | +58.6% | +26.1% | — |
| Gross profit | +126.4% | +206.6% | +23.0% | — |
| Operating income | +111.0% | — | +12.5% | — |
| Net income | +35.7% | — | −7.8% | +96.2% |
| EPS (diluted) | +54.8% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
NUTX quarterly EPS vs estimates
Nutex Health beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 18, 2026 (estimate $5.53).
NUTX income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M | $274.0M | $97.1M | $91,373 | $53,647 | $0 |
| Cost of revenue | $431.0M | $283.7M | $212.9M | $203.9M | $152.3M | $116.4M | $40.2M | $62,298 | $564,367 | $473 |
| Gross profit | $444.3M | $196.3M | $34.8M | $15.4M | $179.3M | $157.6M | $56.9M | $29,075 | $53,647 | −$473 |
| Research & development | — | — | — | — | $285,880 | $557,257 | $768,103 | $545,223 | $25,645 | — |
| Sales, general & admin | $168.7M | $58.6M | $36.1M | $20.0M | $5.5M | $4.4M | $59.9M | $1.2M | $1.8M | — |
| Total operating expenses | $168.7M | $65.6M | $66.5M | $422.0M | $9.0M | $4.4M | $22.2M | $1.8M | $5.7M | $448,122 |
| Operating income | $275.6M | $130.6M | −$31.8M | −$406.6M | $170.3M | $153.2M | $34.7M | −$1.8M | −$5.7M | −$448,600 |
| Interest expense | $22.2M | $19.9M | $16.3M | $12.5M | $6.2M | $6.4M | $3.5M | $642,070 | $367,352 | $2,579 |
| Income before taxes | $244.8M | $109.7M | −$48.5M | −$419.6M | $169.5M | $145.7M | $32.1M | −$2.8M | $582,062 | −$451,060 |
| Income taxes | $64.4M | $14.5M | −$5.1M | $13.1M | $965,731 | $181,341 | $15.6M | −$161,141 | −$535,024 | $7.0M |
| Net income | $70.8M | $52.2M | −$45.8M | −$424.8M | $132.6M | $106.0M | $20.9M | −$2.8M | $582,062 | −$7.4M |
| EBITDA | $287.5M | $148.7M | −$14.6M | −$394.0M | $183.4M | $158.1M | $38.1M | −$1.8M | −$5.7M | −$448,008 |
| EPS (diluted) | $16.39 | $10.59 | −$11.69 | −$1.05 | −$1.44 | −$162.91 | −$440.55 | −$976.76 | $0.16 | — |
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 58.6% | 31.8% | 100.0% | — |
| Operating margin | 31.5% | 27.2% | −12.8% | −185.4% | 51.4% | 55.9% | 35.8% | −2,003.4% | −10,611.8% | — |
| Net margin | 8.1% | 10.9% | −18.5% | −193.7% | 40.0% | 38.7% | 21.6% | −3,080.0% | 1,085.0% | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.8M | $216.5M | $151.7M | $267.8M | $244.0M | $211.8M | $257.6M | $78.8M | $76.1M | $67.5M | $69.7M | $62.7M |
| Cost of revenue | $69.5M | $124.8M | $105.5M | $112.9M | $119.1M | $93.5M | $116.0M | $56.9M | $53.5M | $57.3M | $56.5M | $50.9M |
| Gross profit | $141.3M | $91.7M | $46.1M | $154.9M | $124.9M | $118.3M | $141.6M | $21.9M | $22.6M | $10.2M | $13.2M | $11.8M |
| Sales, general & admin | $19.6M | $14.4M | $17.8M | $11.3M | $91.2M | $10.0M | $27.4M | $11.8M | $10.6M | $8.7M | $9.8M | $7.8M |
| Total operating expenses | $19.6M | $10.5M | $15.2M | $24.5M | $210.3M | $46.1M | $27.4M | $12.3M | $17.3M | $8.7M | $39.4M | $12.6M |
| Operating income | $121.7M | $81.3M | $30.9M | $130.4M | $33.7M | $72.2M | $114.2M | $9.7M | $5.3M | $1.4M | −$26.1M | −$821,226 |
| Interest expense | $4.7M | $4.7M | $5.0M | $5.5M | $5.7M | $6.1M | $5.1M | $5.4M | $5.1M | $4.4M | $4.2M | $4.1M |
| Income before taxes | $117.1M | $76.6M | $25.9M | $123.9M | $23.7M | $62.8M | $108.6M | −$2.6M | $3.9M | −$152,822 | −$30.7M | −$4.9M |
| Income taxes | $20.8M | $13.8M | $9.3M | $27.1M | — | $18.5M | $8.6M | $4.6M | $893,892 | $389,665 | −$3.0M | −$342,259 |
| Net income | $65.8M | $46.8M | $11.8M | $55.4M | −$17.7M | $14.6M | $61.7M | −$8.8M | −$364,048 | −$364,075 | −$31.6M | −$5.5M |
| EBITDA | $127.1M | $86.7M | $36.1M | $134.4M | $34.7M | $74.0M | $118.9M | $7.8M | $13.5M | $8.5M | −$21.8M | $1.1M |
| EPS (diluted) | $9.58 | $5.74 | $1.62 | $7.76 | $5.23 | $1.78 | $11.12 | −$0.32 | −$0.15 | −$0.06 | −$7.50 | −$1.25 |
| Gross margin | 67.0% | 42.4% | 30.4% | 57.8% | 51.2% | 55.9% | 55.0% | 27.8% | 29.7% | 15.1% | 19.0% | 18.8% |
| Operating margin | 57.8% | 37.5% | 20.4% | 48.7% | 13.8% | 34.1% | 44.3% | 12.3% | 7.0% | 2.1% | −37.5% | −1.3% |
| Net margin | 31.2% | 21.6% | 7.8% | 20.7% | −7.3% | 6.9% | 23.9% | −11.2% | −0.5% | −0.5% | −45.4% | −8.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NUTX's financial statements (latest annual report filed March 5, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
NUTX financial results
In fiscal year 2025 (ended December 31, 2025), Nutex Health reported revenue of $875.3 million, up 82.4% from the year before. It had net income of $70.8 million (up 35.7%), a net profit margin of 8.1%. Diluted earnings per share came to $16.39. Over five years revenue grew at an average rate of 26.1% a year.
See the NUTX stock overview for the latest quote and news, or the NUTX chart for price history and technical indicators.
NUTX income statement FAQ
What is Nutex Health's annual revenue?
Nutex Health reported total revenue of $875.3 million for fiscal year 2025, which ended on December 31, 2025. That was up 82.4% from $479.9 million the previous year.
Is Nutex Health profitable?
Yes. Nutex Health reported net income of $70.8 million in fiscal 2025, a net profit margin of 8.1%; its operating margin was 31.5%.
What is Nutex Health's gross margin?
Nutex Health's gross margin was 50.8% in fiscal 2025: for every $100 of revenue, Nutex Health kept $51 after the direct cost of its products and services.
How fast is Nutex Health growing?
Revenue grew 26.1% a year on average over the last five fiscal years, from $274.0 million to $875.3 million.
What are Nutex Health's earnings per share?
Nutex Health earned $16.39 per diluted share in fiscal 2025, compared with $10.59 a year earlier.
When will Nutex Health report its next earnings?
Nutex Health is expected to report results for the quarter ending September 30, 2026 on November 18, 2026.
When does Nutex Health's fiscal year end?
Nutex Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 5, 2026.